Management ChangeApr 14, 2026, 12:50 PM
Harmony Biosciences Appoints Glenn Reicin as New CFO
AI Summary
Harmony Biosciences Holdings, Inc. announced a change in its Chief Financial Officer role, effective April 14, 2026. Sandip Kapadia stepped down to pursue other career opportunities and will receive severance benefits in accordance with his employment agreement. Glenn Reicin, aged 61, has been appointed as the new Chief Financial Officer. Mr. Reicin brings significant experience, having previously served as CFO at Eccogene, Inc. and as CFO and COO at Alladapt Immunotherapeutics, Inc.
Key Highlights
- Sandip Kapadia resigned as Chief Financial Officer, effective April 14, 2026.
- Kapadia will receive severance payments and benefits as per his employment agreement.
- Glenn Reicin, 61, was appointed as the new Chief Financial Officer, effective April 14, 2026.
- Reicin previously served as CFO at Eccogene, Inc. and CFO & COO at Alladapt Immunotherapeutics, Inc.
Price Impact
More from HRMY